Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis

References

• Martin Lopez JE. Candidiasis (vulvovaginal). BMJ Clin Evid. 2015;16.
   Google Scholar
• Nwadioha SI, Nwokedi EO, Egesie J, Enejuo H. Vaginal candidiasis and its risk factors among women attending a Nigerian teaching hospital. Niger Postgrad Med J. 2013;20(1):20–23.
   PubMedGoogle Scholar
• Rathod SD, Buffler PA. Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented. BMC Womens Health. 2014;14(1):1472–6874.
   Google Scholar
• Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905–927.
   PubMed Web of Science ®Google Scholar
• Mikamo H, Kawazoe K, Sato Y, Hayasaki Y, Tamaya T. Comparative study on the effectiveness of antifungal agents in different regimens against vaginal candidiasis. Chemotherapy. 1998;44(5):364–368.
   PubMed Web of Science ®Google Scholar
• Dovnik A, Golle A, Novak D, Arko D, Takač I. Treatment of vulvovaginal candidiasis: a review of the literature. Acta Dermatovenerol Alp Pannonica Adriat. 2015;24(1):5–7.
   PubMed Web of Science ®Google Scholar
• A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Report of an international multicentre trial. Br J Obstet Gynaecol. 1989;96(2):226–232.
   PubMedGoogle Scholar
• Corić M, Barisić D, Lovrić H. Fluconazole versus 3-day clotrimazole in the treatment of sporadic and recurrent vulvovaginal candidiasis. Int J Gynaecol Obstet. 2006;95(2):171–172.
   PubMed Web of Science ®Google Scholar
• Costa M, Passos XS, Miranda AT, de Araújo RS, Paula CR, Silva MR. Correlation of in vitro itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis. Mycopathologia. 2004;157(1):43–47.
   PubMed Web of Science ®Google Scholar
• de Punzio C, Garutti P, Mollica G, Nappi C, Piccoli R, Genazzani AR. Fluconazole 150 mg single dose versus itraconazole 200 mg per day for 3 days in the treatment of acute vaginal candidiasis: a double-blind randomized study. Eur J Obstet Gynecol Reprod Biol. 2003;106(2):193–197.
   PubMed Web of Science ®Google Scholar
• Fan S, Liu X, Liang Y. Miconazole nitrate vaginal suppository 1,200 mg versus oral fluconazole 150 mg in treating severe vulvovaginal candidiasis. Gynecol Obstet Invest. 2015;80(2):113–118.
   PubMed Web of Science ®Google Scholar
• Ferahbas A, Koc AN, Uksal U, Aygen E, Mistik S, Yildiz S. Terbinafine versus itraconazole and fluconazole in the treatment of Vulvovaginal candidiasis. Am J Ther. 2006;13(4):332–336.
   PubMedGoogle Scholar
• Li T, Zhu Y, Fan S, Liu X, Xu H, Liang Y. A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis. Med Mycol. 2015;53(5):455–461.
   PubMed Web of Science ®Google Scholar
• Mcclelland RS, Balkus JE, Lee J, et al. Randomized trial of periodic presumptive treatment with high-dose intravaginal metronidazole and miconazole to prevent vaginal infections in HIV-negative women. J Infect Dis. 2015;211(12):1875–1882.
   PubMed Web of Science ®Google Scholar
• Mendling W, Krauss C, Fladung B. A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses. Mycoses. 2004;47(3-4):136–142.
   PubMed Web of Science ®Google Scholar
• Mikamo H, Izumi K, Ito K, Tamaya T. Comparative study of the effectiveness of oral fluconazole and intravaginal clotrimazole in the treatment of vaginal candidiasis. Infect Dis Obstet Gynecol. 1995;3(1):7–11.
   PubMedGoogle Scholar
• O-Prasertsawat P, Bourlert A. Comparative study of fluconazole and clotrimazole for the treatment of vulvovaginal candidiasis. Sex Transm Dis. 1995;22(4):228–230.
   PubMed Web of Science ®Google Scholar
• Osser S, Haglund A, Weström L. Treatment of candidal vaginitis. A prospective randomized investigator-blind multicenter study comparing topically applied econazole with oral fluconazole. Acta Obstet Gynecol Scand. 1991;70(1):73–78.
   PubMed Web of Science ®Google Scholar
• Seidman LS, Skokos CK. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis. Infect Dis Obstet Gynecol. 2005;13(4):197–206.
   PubMedGoogle Scholar
• Sekhavat L, Tabatabaii A, Tezerjani FZ. Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis. J Infect Public Health. 2011;4(4):195–199.
   PubMedGoogle Scholar
• Sobel JD, Brooker D, Stein GE, et al. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group. Am J Obstet Gynecol. 1995;172(4 Pt 1):1263–1268.
   PubMed Web of Science ®Google Scholar
• Sobel JD, Wiesenfeld HC, Martens M, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351(9):876–883.
   PubMed Web of Science ®Google Scholar
• Stein GE, Christensen S, Mummaw N. Comparative study of fluconazole and clotrimazole in the treatment of vulvovaginal candidiasis. DICP. 1991;25(6):582–585.
   PubMedGoogle Scholar
• Stein GE, Mummaw N. Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis. Antimicrob Agents Chemother. 1993;37(1):89–92.
   PubMed Web of Science ®Google Scholar
• Timonen H. Shorter treatment for vaginal candidosis: comparison between single-dose oral fluconazole and three-day treatment with local miconazole. Mycoses. 1992;35(11-12):317–320.
   PubMed Web of Science ®Google Scholar
• Tobin JM, Loo P, Granger SE. Treatment of vaginal candidosis: a comparative study of the efficacy and acceptability of itraconazole and clotrimazole. Genitourin Med. 1992;68(1):36–38.
   PubMedGoogle Scholar
• van Heusden AM, Merkus HM, Corbeij RS, et al. Single-dose oral fluconazole versus single-dose topical miconazole for the treatment of acute vulvovaginal candidosis. Acta Obstet Gynecol Scand. 1990;69(5):417–422.
   PubMed Web of Science ®Google Scholar
• Zhou X, Li T, Fan S, et al. The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis. Mycoses. 2016;59(7):419–428.
   PubMed Web of Science ®Google Scholar
• Fong IW. The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis. Genitourin Med. 1992;68(6):374–377.
   PubMedGoogle Scholar
• Puolakka J, Tuimala R. Comparison between oral ketoconazole and topical miconazole in the treatment of vaginal candidiasis. Acta Obstet Gynecol Scand. 1983;62(6):575–577.
   PubMed Web of Science ®Google Scholar
• Corson SL, Kapikian RR, Nehring R. Terconazole and miconazole cream for treating vulvovaginal candidiasis. A comparison. J Reprod Med. 1991;36(8):561–567.
   PubMed Web of Science ®Google Scholar
• Thomason JL, Gelbart SM, Kellett AV, Scaglione NJ, Gotwalt KT, Broekhuizen FF. Terconazole for the treatment of vulvovaginal candidiasis. J Reprod Med. 1990;35(11):992–994.
   PubMed Web of Science ®Google Scholar
• Brown D, Henzl MR, Lepage ME, et al. Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo. J Reprod Med. 1986;31(11):1045–1048.
   PubMed Web of Science ®Google Scholar
• Adamson GD, Brown D, Standard JV, Henzl MR. Three-day treatment with butoconazole vaginal suppositories for vulvovaginal candidiasis. J Reprod Med. 1986;31(2):131–132.
   PubMed Web of Science ®Google Scholar
• Stettendorf S, Benijts G, Vignali M, Kreysing W. Three-day therapy of vaginal candidiasis with clotrimazole vaginal tablets and econazole ovules: a multicenter comparative study. Chemotherapy. 1982;28 Suppl 1:87–91.
   Google Scholar
• Perera J, Seneviratne HR. Econazole and clotrimazole in the treatment of vaginal candidiasis: a double blind comparative study. Ceylon Med J. 1994;39(3):132–134.
   PubMedGoogle Scholar
• Kaufman RH, Henzl MR, Brown D, et al. Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis. J Reprod Med. 1989;34(7):479–483.
   PubMed Web of Science ®Google Scholar
• Hajman AJ. Vulvovaginal candidosis: comparison of 3-day treatment with 2% butoconazole nitrate cream and 6-day treatment with 1% clotrimazole cream. J Int Med Res. 1988;16(5):367–375.
   PubMed Web of Science ®Google Scholar
• Brown D, Henzl MR, Kaufman RH. Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group. J Reprod Med. 1999;44(11):933–938.
   PubMed Web of Science ®Google Scholar
• Ruf H, Vitse M. A comparison of butoconazole nitrate cream with econazole nitrate cream for the treatment of vulvovaginal candidiasis. J Int Med Res. 1990;18(5):389–399.
   PubMed Web of Science ®Google Scholar
• Rohde-Werner H. Topical tioconazole versus systemic ketoconazole treatment of vaginal candidiasis. J Int Med Res. 1984;12(5):298–302.
   PubMed Web of Science ®Google Scholar
• Sobel JD, Schmitt C, Stein G, Mummaw N, Christensen S, Meriwether C. Initial management of recurrent vulvovaginal candidiasis with oral ketoconazole and topical clotrimazole. J Reprod Med. 1994;39(7):517–520.
   PubMed Web of Science ®Google Scholar
• Gerhard I, Ohlhorst D, Eggert-Kruse W, Runnebaum B. Topical one-time therapy with ketoconazole: a double-blind randomized study in vaginal mycosis. Mycoses. 1989;32(5):253–265.
   PubMed Web of Science ®Google Scholar
• Sobel JD. Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med. 1986;315(23):1455–1458.
   PubMed Web of Science ®Google Scholar
• van der Meijden WI, van der Hoek JC, Staal HJ, van Joost T, Stolz E. Double-blind comparison of 200-mg ketoconazole oral tablets and 1200-mg miconazole vaginal capsule in the treatment of vaginal candidosis. Eur J Obstet Gynecol Reprod Biol. 1986;22(3):133–138.
   PubMed Web of Science ®Google Scholar
• Kutzer E, Oittner R, Leodolter S, Brammer KW. A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial. Eur J Obstet Gynecol Reprod Biol. 1988;29(4):305–313.
   PubMed Web of Science ®Google Scholar
• Hong E, Dixit S, Fidel PL, Bradford J, Fischer G. Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition. J Low Genit Tract Dis. 2014;18(1):31–38.
   PubMed Web of Science ®Google Scholar
• Zhang JY, Liu JH, Liu FD, et al. Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression. Mycoses. 2014;57(10):584–591.
   PubMed Web of Science ®Google Scholar
• Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis. 2013;17(3):340–345.
   PubMed Web of Science ®Google Scholar
• Fardiazar Z, Ronaci F, Torab R, Goldust M. Vulvovaginitis candidiasis recurrence during pregnancy. Pak J Biol Sci. 2012;15(8):399–402.
   PubMedGoogle Scholar
• Goldacre MJ, Watt B, Loudon N, Milne LJ, Loudon JD, Vessey MP. Vaginal microbial flora in normal young women. Br Med J. 1979;1(6176):1450–1455.
   PubMedGoogle Scholar
• Guzel AB, Ilkit M, Akar T, Burgut R, Demir SC. Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species. Med Mycol. 2011;49(1):16–25.
   PubMed Web of Science ®Google Scholar
• Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1–137.
   PubMed Web of Science ®Google Scholar
• Lalla RV, Dongari-Bagtzoglou A. Antifungal medications or disinfectants for denture stomatitis. Evid Based Dent. 2014;15(2):61–62.
   PubMedGoogle Scholar
• Peyton LR, Gallagher S, Hashemzadeh M. Triazole antifungals: a review. Drugs Today. 2015;51(12):705–718.
   PubMed Web of Science ®Google Scholar
• Eschenauer GA, Nguyen MH, Clancy CJ. Is fluconazole or an echinocandin the agent of choice for candidemia. Ann Pharmacother. 2015;49(9):1068–1074.
   PubMed Web of Science ®Google Scholar
• Wildfeuer A, Laufen H, Schmalreck AF, Yeates RA, Zimmermann T. Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility. Mycoses. 1997;40(7–8):259–265.
   PubMed Web of Science ®Google Scholar
• Kjaeldgaard A. Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis. Pharmatherapeutica. 1986;4(8):525–531.
   PubMedGoogle Scholar